epirubicin has been researched along with Abnormalities, Autosome in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haruta, M; Higuchi, T; Inoue, K; Kaneko, Y; Kasai, F; Kurosumi, M; Miyazaki, M; Ogawa, S; Sato-Otsubo, A; Takada, M; Takei, H; Tozuka, K; Watanabe, J | 1 |
| Carrara, HH; Silva, LM; Takahashi, CS | 1 |
| Berger, M; Karaivanova, M; Konstantinov, S; Martinova, Y; Petkova, S; Topashka-Ancheva, M | 1 |
| Campbell, L; de Silva, M; Hu, XF; Kaczmarczyk, SJ; Kantharidis, P; Nadalin, G; Parkin, JD; Vrazas, V; Wall, DM; Zalcberg, JR | 1 |
| Arbona, C; Benet, I; Comes, AM; García Clavel, B; García-Conde, J; Lluch, A; Martínez-Climent, JA; Marugán, I; Prósper, F; Solano, C; Vizcarra, E | 1 |
| El-Mahdy Sayed Othman, O | 1 |
| Alloisio, M; Balzarotti, M; Bertuzzi, A; Castagna, L; Compasso, S; Nozza, A; Quagliuolo, V; Santoro, A; Siracusano, L; Soto Parra, H | 1 |
| Koumkoumadjian, VA; Nersessian, AK; Zilfian, VN | 1 |
| Kumkumadzhian, VA; Nersesian, AK; Zil'fian, VN | 1 |
| Khachatrian, GA; Nerseian, AK; Proshian, NV | 1 |
1 trial(s) available for epirubicin and Abnormalities, Autosome
| Article | Year |
|---|---|
High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Melphalan; Middle Aged; Mitoxantrone; Neuroectodermal Tumors, Primitive, Peripheral; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma; Survival Analysis; Thiotepa; Vincristine | 2002 |
9 other study(ies) available for epirubicin and Abnormalities, Autosome
| Article | Year |
|---|---|
Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemot
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Chromosome Aberrations; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Gene Dosage; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Kaplan-Meier Estimate; Neoadjuvant Therapy; Oligonucleotide Array Sequence Analysis; Paclitaxel; Phosphatidylinositol 3-Kinases; Polymorphism, Single Nucleotide; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Signal Transduction; Survival Rate; Trastuzumab | 2013 |
Study of chromosome damage in patients with breast cancer treated by two antineoplastic treatments.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Division; Chromosome Aberrations; Chromosomes, Human; Cyclophosphamide; DNA Damage; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitotic Index; Sister Chromatid Exchange | 2002 |
Miltefosine decreases the cytotoxic effect of epirubicine and cyclophosphamide on mouse spermatogenic, thymic and bone marrow cells.
Topics: Animals; Antineoplastic Agents; Bone Marrow Cells; Chromosome Aberrations; Chromosomes; Cyclophosphamide; Drug Interactions; Epirubicin; Female; Male; Mice; Mice, Inbred C57BL; Mutagens; Phosphorylcholine; Spermatogenesis; Spermatozoa; Testis; Thymus Gland | 2006 |
Inheritance of chromosome 7 is associated with a drug-resistant phenotype in somatic cell hybrids.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Chromosome Aberrations; Chromosomes, Human, Pair 7; DNA Primers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Humans; Hybrid Cells; Leukemia, Lymphoid; Molecular Sequence Data; Phenotype; Polymerase Chain Reaction; Rabbits; Tumor Cells, Cultured | 1996 |
Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Chemotherapy, Adjuvant; Chromosome Aberrations; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Middle Aged; Myelodysplastic Syndromes; Neoplasm Staging; Neoplasms, Second Primary; Postmenopause; Predictive Value of Tests; Premenopause; Transplantation, Autologous | 2000 |
Cytogenetic effect of the anticancer drug epirubicin on Chinese hamster cell line in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Biotransformation; CHO Cells; Chromosome Aberrations; Chromosomes; Cricetinae; Cricetulus; Epirubicin; Mitotic Index; Molecular Structure; Sister Chromatid Exchange | 2000 |
Inhibitory effect of rat immunization with tularemia vaccine on the in vivo clastogenicity of 4 anthracycline antibiotics.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Bacterial Vaccines; Bone Marrow Cells; Chromosome Aberrations; Doxorubicin; Epirubicin; Francisella tularensis; Injections, Intradermal; Liver; Male; Mutation; Rats; Rats, Inbred Strains | 1991 |
[Relation of the antitumor activity of 4'-epidoxorubicin and cytogenetic disorders of tumor cells in experimental studies].
Topics: Animals; Carcinoma, Ehrlich Tumor; Chromosome Aberrations; Epirubicin; Female; Megakaryocytes; Ovarian Neoplasms; Ovary; Rats; Rats, Inbred Strains | 1990 |
[Cytogenetic effect of the antineoplastic anthracycline antibiotic 4'-epidoxorubicin].
Topics: Animals; Bone Marrow; Chromosome Aberrations; Dose-Response Relationship, Drug; Epirubicin; Female; Male; Megakaryocytes; Mutation; Rats; Rats, Inbred Strains; Time Factors | 1989 |